Article Information
- Received August 15, 2024
- Revision received February 9, 2025
- Accepted February 12, 2025
- Published online March 31, 2025.
Author Information
- 1Department of Molecular and Human Genetics, Baylor College of Medicine (BCM), Houston, Texas 77030
- 2Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, Texas 77030
- 3Department of Neuroscience, BCM, Houston, Texas 77030
- 4Department of Pediatrics, BCM, Houston, Texas 77030
- 5Department of Neurology, BCM, Houston, Texas 77030
- 6Howard Hughes Medical Institute, Houston, Texas 77030
- Correspondence should be addressed to Huda Y. Zoghbi at hzoghbi{at}bcm.edu.
Author contributions
Author contributions: Y.K., J.M., and H.Y.Z. designed research; Y.K., B.V., and J.M. performed research; Y.K. contributed unpublished reagents/analytic tools; Y.K. and H.Y.Z. analyzed data; Y.K. and H.Y.Z. wrote the paper.
Disclosures
H.Y.Z. cofounded Cajal Neuroscience, is a Director of Regeneron Pharmaceuticals board, and is on the scientific advisory board of Cajal Neuroscience, Lyterian, and the Column Group.
We appreciate Kristyn Gonzales, Yanhong Wei Liang, and Surabi Veeraragavan's technical support. We thank Jiyoen Kim, Xue Deng, and Hamin Lee for their critical comments on the manuscript. We further thank the Baylor College of Medicine (BCM), Genetically Engineered Mouse Core, and the following cores (Microscopy Core and Animal Behavior Core) supported by the Jan and Dan Duncan Neurological Research Institute (NRI) and the BCM-IDDRC (U54HD083092) from the Eunice Kennedy Shriver National Institute of Child Health and Development. This work is supported by the Huffington Foundation and Howard Hughes Medical Institute.
Funding
Huffington Foundation
Howard Hughes Medical Institute (HHMI)
Other Version
- You are viewing the most recent version of this article.
- previous version (March 31, 2025).
Article usage
In this issue
